GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRay Technology Co Ltd (SHSE:688301) » Definitions » Capex-to-Revenue

iRay Technology Co (SHSE:688301) Capex-to-Revenue : 1.15 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is iRay Technology Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

iRay Technology Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-562.46 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥490.91 Mil.

Hence, iRay Technology Co's Capex-to-Revenue for the three months ended in Mar. 2024 was 1.15.


iRay Technology Co Capex-to-Revenue Historical Data

The historical data trend for iRay Technology Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRay Technology Co Capex-to-Revenue Chart

iRay Technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.07 0.02 0.16 0.46 1.00

iRay Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.59 0.60 2.02 1.15

Competitive Comparison of iRay Technology Co's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, iRay Technology Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRay Technology Co's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRay Technology Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where iRay Technology Co's Capex-to-Revenue falls into.



iRay Technology Co Capex-to-Revenue Calculation

iRay Technology Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1853.611) / 1863.789
=0.99

iRay Technology Co's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-562.455) / 490.912
=1.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iRay Technology Co  (SHSE:688301) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


iRay Technology Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of iRay Technology Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


iRay Technology Co (SHSE:688301) Business Description

Traded in Other Exchanges
N/A
Address
No.590 Ruiqing Road, Room 202, 2nd Floor, Building 9, Pudong New Area, Shanghai, CHN, 201201
iRay Technology Co Ltd is engaged in development and manufacturing of key X-ray system components used in medical, dental, veterinary and industrial imaging applications. The company's products portfolio includes Wireless Radiography Detectors; Tethered Radiography Detectors; Mammography Detectors; Dynamic/Real-time Detectors; Linear Detector Arrays; Software; and Other.
Executives
Director
Directors, senior managers, core technical personn

iRay Technology Co (SHSE:688301) Headlines

No Headlines